Received Feb 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | 1 | — | — |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | — | — |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | 3 | — | — |
| PPV | PNEUMO (NO BRAND NAME) | UNKNOWN MANUFACTURER | 4 | — | — |
patient vaccinated with the fourth dose of pneumococcal vaccine on 17-FEB-2006 at the age reported as 1y0mo; patient vaccinated with the fourth dose of pneumococcal vaccine on 17-FEB-2006 at the age reported as 1y0mo; patient vaccinated with the third dose pneumococcal vaccine on 16-AUG-2005 at the age reported as 6m3do; patient vaccinated with the third dose pneumococcal vaccine on 16-AUG-2005 at the age reported as 6m3do; patient vaccinated with the second dose of pneumococcal vaccine on 14-JUN-2005 at the age reported as 4m1do; patient vaccinated with the second dose of pneumococcal vaccine on 14-JUN-2005 at the age reported as 4m1do; patient vaccinated with the first dose of pneumococcal vaccine on 12-APR-2005 at the age reported as 1m30do; This spontaneous report, which is a split case from a case in litigation for human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9) (case ID in previous safety database: 2501USA003441; current case ID: 2249222), has been received via medical records from a physician and refers to a 1-month-old female patient. The patient's medical history, current conditions and concomitant therapies have already been reported in the above-mentioned case in litigation. On 12-Apr-2005, the patient was vaccinated with the first dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) solution for injection, provided as "pneumococcal" vaccine (exact dose, lot #, expiration date, route of administration and anatomical location not reported), for prophylaxis, at the age reported as "1m30do" (Inappropriate age at vaccine administration). On 14-Jun-2005, the patient was vaccinated with the second dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) solution for injection (exact dose, lot #, expiration date, route of administration and anatomical location not reported), for prophylaxis, at the age reported as "4m1do" (Inappropriate age at vaccine administration, Extra dose administered). On 16-Aug-2005, the patient was vaccinated with the third dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) solution for injection (exact dose, lot #, expiration date, route of administration and anatomical location not reported), for prophylaxis, at the age reported as "6m3do" (Inappropriate age at vaccine administration, Extra dose administered). On 17-Feb-2006, the patient was vaccinated with the fourth dose of pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) solution for injection (exact dose, lot #, expiration date, route of administration and anatomical location not reported), for prophylaxis, at the age reported as "1y0mo" (Inappropriate age at vaccine administration, Extra dose administered). This is one of several reports pertaining to the same patient (cross-referenced with case # US-009507513-2501USA003441). All available medical records will be provided upon request.